Inferior venacavogram 4.
Denies headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, palpitations, abdominal pain, nausea, diarrhea, constipation, BRBPR, melena, hematochezia.
Physical Exam: VS: T98.1, BP 136/77, Pulse 90, RR 16, O2 sat 99 on RA GEN: Middle-aged man in NAD, awake, alert NECK: Supple, no JVD, no carotid bruits CV: RRR, normal S1, S2.
Fem  DP  PT R  P   P    P L  P   P    P   Pertinent Results: [**2190-1-9**] 02:14AM BLOOD WBC-5.2# RBC-3.48* Hgb-11.0* Hct-31.1* MCV-89 MCH-31.6# MCHC-35.3*# RDW-16.8* Plt Ct-229# [**2190-1-9**] 09:10AM BLOOD WBC-5.5 RBC-3.62* Hgb-11.1* Hct-32.2* MCV-89 MCH-30.6 MCHC-34.4 RDW-16.7* Plt Ct-241 [**2190-1-17**] 07:55AM BLOOD WBC-8.9 RBC-3.65* Hgb-11.2* Hct-32.2* MCV-88 MCH-30.7 MCHC-34.7 RDW-17.3* Plt Ct-390 [**2190-1-18**] 07:00AM BLOOD WBC-7.9 RBC-3.58* Hgb-11.0* Hct-31.7* MCV-89 MCH-30.8 MCHC-34.7 RDW-17.5* Plt Ct-433 [**2190-1-9**] 02:14AM BLOOD PT-24.5* PTT-39.0* INR(PT)-2.4* [**2190-1-9**] 02:14AM BLOOD Plt Ct-229# [**2190-1-14**] 05:50PM BLOOD PT-25.6* PTT-79.2* INR(PT)-2.5* [**2190-1-15**] 07:10AM BLOOD PT-27.8* PTT-125.6* INR(PT)-2.8* [**2190-1-15**] 10:15AM BLOOD PT-32.0* PTT-130.3* INR(PT)-3.3* [**2190-1-16**] 09:20AM BLOOD PT-39.9* PTT-97.7* INR(PT)-4.3* [**2190-1-17**] 07:55AM BLOOD PT-39.7* PTT-41.8* INR(PT)-4.3* [**2190-1-18**] 07:00AM BLOOD PT-33.7* PTT-38.3* INR(PT)-3.5* [**2190-1-10**] 11:29AM BLOOD Fibrino-461* [**2190-1-10**] 03:48PM BLOOD Fibrino-343 [**2190-1-10**] 07:47PM BLOOD Fibrino-241 [**2190-1-9**] 09:10AM BLOOD Glucose-131* UreaN-9 Creat-0.7 Na-131* K-4.8 Cl-96 HCO3-27 AnGap-13 [**2190-1-16**] 09:20AM BLOOD Glucose-103 UreaN-7 Creat-0.8 Na-137 K-3.8 Cl-99 HCO3-27 AnGap-15 [**2190-1-18**] 07:00AM BLOOD Glucose-99 UreaN-9 Creat-0.8 Na-137 K-3.8 Cl-99 HCO3-28 AnGap-14 [**2190-1-10**] 07:47PM BLOOD ALT-24 AST-46* LD(LDH)-1094* AlkPhos-60 Amylase-41 TotBili-1.3  Brief Hospital Course: The patient was transferred from medicine to the surgery service for evaluation and definitive treatment.
He continued his heparin drip until POD 7 when his INR was supratherapeutic at 4.3, and his heparin gtt was stopped shortly thereafter.
His coumadin was held on this day, and his INR dropped down to 3.5 after one further day of 2.5mg.
His discharge INR was 3.5, with a goal range between 3 and 3.5.
CV:  The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored and did not stray from normal.
The patient's electrolytes were routinely followed during this hospitalization, and repleted when necessary.
ID: The patient's white blood count and fever curves were closely watched for signs of infection.
Hematology:  The patient's complete blood count was examined routinely; no transfusions were required during this stay.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily).
Temperature greater than 101.5F for 24 hours ??????
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1244**], MD Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2190-1-29**] 11:30 Provider: [**Name10 (NameIs) **] LAB Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2190-2-16**] 8:00 Provider: [**Name10 (NameIs) **] LAB Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2190-2-16**] 8:45  Call your primary care doctor tomorrow, [**1-19**] to follow up the results of your INR test.
